KCNA3 and cardiac rhythm disease: In this work, we treated type 2 diabetic rats with PAP1 in order to determine whether Kv1.3 blockade improves the diabetes-induced low-grade inflammation, prevents the electrophysiological alterations, and thus protects against cardiac arrhythmia.